Mass General Brigham · Boston, MA
Not rated by CMS
CMS star rating
41
Beds
1,553
Inpatient discharges a year
$347.3M
Net patient revenue a year
33
In-network payers
Mass Eye & Ear Infirmary is a 41-bed voluntary non-profit - private hospital in Boston, MA, affiliated with Mass General Brigham. Below you'll find publicly disclosed negotiated rates and facility details, including 33 in-network payers and 178 disclosed rate categories.
The 24 services Mass Eye & Ear Infirmary most likely performs, ranked by likely volume and what it is paid. Each service names one insurer. * marks hidden insurer names; A, B and C rank the remaining rates from low to high and reset for each service.
Book a demo to see hidden insurer names, more payer rates, and hospital data, or start a free trial.
Ear, nose and throat
CPT 69436
$958 - $2,194
from 4 insurers · median $1,795
230 Medicare claims in Level 3 ENT Procedures (CMS 2024)
CT imaging
CPT 74177
$268 - $1,141
from 4 insurers · median $897
Common here, based on CMS Medicare volume
Medicine & Surgery
CPT 66984
$2,228 - $3,096
from 4 insurers · median $2,497
3528 Medicare claims in Level 1 Intraocular Procedures (CMS 2024)
CT imaging
CPT 70450
$177 - $711
from 4 insurers · median $411
Common here, based on CMS Medicare volume
Mammography
CPT 77067
$103 - $275
from 2 insurers · median $189
Common here, based on CMS Medicare volume
Cardiology and vascular testing
CPT 93306
$248 - $1,311
from 2 insurers · median $780
Common here, based on CMS Medicare volume
MRI imaging
CPT 70553
$934 - $1,289
from 4 insurers · median $1,218
Common here, based on CMS Medicare volume
CT imaging
CPT 71275
$459 - $1,678
from 4 insurers · median $884
Common here, based on CMS Medicare volume
CT imaging
CPT 71260
$265 - $1,140
from 4 insurers · median $668
Common here, based on CMS Medicare volume
Nuclear imaging
CPT 78452
$576 - $4,047
from 2 insurers · median $2,311
Common here, based on CMS Medicare volume
X-ray and bone density
CPT 71046
$69 - $110
from 3 insurers · median $109
Common here, based on CMS Medicare volume
Digestive procedures
CPT 45385
$873 - $1,725
from 2 insurers · median $1,299
Common here, based on CMS Medicare volume
Ear, nose and throat
CPT 30520
$1,264 - $2,228
from 4 insurers · median $1,666
105 Medicare claims in Level 4 ENT Procedures (CMS 2024)
MRI imaging
CPT 74183
$925 - $1,342
from 2 insurers · median $1,134
Common here, based on CMS Medicare volume
Digestive procedures
CPT 45380
$751 - $1,725
from 3 insurers · median $1,206
Common here, based on CMS Medicare volume
MRI imaging
CPT 70551
$420 - $2,023
from 4 insurers · median $947
Common here, based on CMS Medicare volume
Digestive procedures
CPT 43239
$598 - $1,725
from 3 insurers · median $871
Common here, based on CMS Medicare volume
Digestive procedures
CPT 45378
$669 - $1,725
from 2 insurers · median $1,197
Common here, based on CMS Medicare volume
MRI imaging
CPT 72148
$467 - $759
from 2 insurers · median $613
Common here, based on CMS Medicare volume
Medicine & Surgery
CPT 42820
$2,228 - $3,317
from 2 insurers · median $2,772
Typical for a hospital with this service line
Gynecology
CPT 58571
$5,093
negotiated rate
Typical for a hospital with this service line
Ultrasound
CPT 76830
$59 - $199
from 2 insurers · median $129
Common here, based on CMS Medicare volume
Ultrasound
CPT 76856
$59 - $199
from 2 insurers · median $129
Common here, based on CMS Medicare volume
Lung function and sleep
CPT 94060
$349 - $746
from 2 insurers · median $547
Common here, based on CMS Medicare volume
Median rate as a percent of Medicare across the outpatient services above, and how many services sit above or below the same insurer's median at nearby hospitals. * marks hidden insurer names. These table labels track the same insurers across services; the labels on each service card reset.
| Insurer | Services | Median % of Medicare | Above nearby | Below nearby |
|---|---|---|---|---|
| Insurer A* | 12 | 277% | 2 | 5 |
| Insurer B* | 21 | 187% | 0 | 9 |
| Insurer C* | 13 | 131% | 1 | 6 |
| Insurer D* | 22 | 125% | 1 | 13 |
How we chose these services: 3 appear in this hospital's own Medicare claims, 19 are common here based on CMS Medicare volume, and 2 are typical for the service lines it reports to CMS. Rates come from insurer and hospital price transparency files as of October 2026. Rates under a quarter of Medicare or over 20 times Medicare are left out as likely physician-fee rows or file errors. Book a demo to see all 300 CMS shoppable services for Mass Eye & Ear Infirmary, or start a free trial.
Acceptance varies by plan and service. Confirm coverage with your insurer or the hospital's billing department.
Quality
Not rated by CMS
Doctors and services
Accredited by The Joint Commission
Finances
$347.3M net patient revenue
Ownership and leadership
Owned by Mass General Brigham Incorporated
The employer identification numbers (EINs) health plans and networks list for Mass Eye & Ear Infirmary in the in-network rate files they publish, with the organization NPIs billed under each.
| Tax ID (EIN) | Plans and networks listing it | Organization NPIs |
|---|---|---|
| 04-2103591Massachusetts Eye & Ear Infirmary | 62Aetna, Cigna, United Healthcare (incl Optum, Rocky Mountain, Health Plan of Nevada, Sierra Health), Allied Benefit Systems, Aspirus Health Plan and 57 more | 1639101751 Massachusetts Eye And Ear Infirmary1649437260 Massachusetts Eye And Ear Infirmary-pharmacy1932574332 Massachusetts Eye And Ear Associates Inc. |
Source: PayerPrice analysis of insurers' Transparency in Coverage in-network files. An EIN can cover several hospitals and clinics in a health system, and insurers sometimes list other organizations' NPIs under it.
243 Charles Street, Boston, MA 02114
(617) 523-7900
How Mass Eye & Ear Infirmary compares with other US facilities on the measures CMS publishes, mostly from Medicare patients.
Death rates
No different on 1 measures
0 better, 1 no different, 0 worse than the US rate
Deaths within 30 days, such as after a heart attack, pneumonia or stroke
Safety
No different on 2 measures
0 better, 2 no different, 0 worse than the US rate
Infections, surgical complications and other harm in the hospital
Readmissions
No different on 2 measures
0 better, 2 no different, 0 worse than the US rate
Patients back in the hospital or ER soon after leaving
Patient survey rating
4 of 5
Higher than 60% of US hospitals
From the HCAHPS survey of recent inpatients
Would definitely recommend
83%
Higher than 87% of US hospitals
US median: 71%
Surveyed patients who would definitely recommend the hospital
Hospital-acquired condition penalty
Penalized
Among the worst-performing 25% of US hospitals
Medicare cuts payments 1% for the worst-performing 25% of hospitals on infections and injuries acquired in the hospital
Serious complications (PSI 90)
0.83
Lower than 89% of US hospitals
US median: 0.96
Risk-adjusted composite of complications such as bedsores, falls with hip fracture and blood clots after surgery; lower is better
Time in the ER before going home
174 min
Higher than 67% of US hospitals
US median: 148 min
Median minutes from arrival to leaving for ER patients who were sent home; lower is better
| Measure | Result | Period |
|---|---|---|
| Death rates | No different on 1 measures | |
| Safety | No different on 2 measures | |
| Readmissions | No different on 2 measures | |
| Patient survey ratingCMS: Summary star rating | 4 of 5 | 2024-10-01 to 2025-09-30 |
| Would definitely recommendCMS: "YES", patients would definitely recommend the hospital | 83% | 2024-10-01 to 2025-09-30 |
| Hospital-acquired condition penaltyCMS: HAC Reduction Program payment reduction | Penalized | 2026 |
| Serious complications (PSI 90)CMS: Patient safety and adverse events composite (PSI 90) | 0.83 | 2022-07-01 to 2024-06-30 |
| Time in the ER before going homeCMS: Average (median) time patients spent in the emergency department before leaving from the visit, excluding patients transferred to another facility or psychiatric care/mental health patients. A lower number of minutes is better | 174 min | 2024-10-01 to 2025-09-30 |
Source: CMS Provider Data Catalog, released 2026-08-13. US comparisons rank this facility among every facility CMS reports for each measure. See Medicare Care Compare.
How Medicare adjusts Mass Eye & Ear Infirmary's inpatient payments for its readmissions, quality and cost results.
No penalty
Readmissions penalty
Hospital Readmissions Reduction Program adjustment for excess readmissions, as estimated in the FY 2027 IPPS final rule.
0.00% on Medicare payments
Value-based purchasing
Hospital Value-Based Purchasing bonus or reduction for quality and cost, as estimated in the FY 2027 IPPS final rule.
Source: CMS IPPS final rule Impact File (FY 2027).
Each result CMS publishes for Mass Eye & Ear Infirmary, beside the US median and the average of MA hospitals. The rank says what share of US hospitals the result is better or worse than; counts and confidence limits are not ranked.
Risk-adjusted 30-day death rates and surgical complications; lower is better.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Rate of complications for hip/knee replacement patients2023-04-01 to 2025-03-31 | Not Available | 4.091 | |||
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality Rate2024-07-01 to 2025-06-30 · 284 cases | 4 | 3.9 | 3.416 | Worse than 51% of US hospitals | |
| Death rate for heart attack patients2022-07-01 to 2025-06-30 | Not Available | 11.44 | |||
| Death rate for CABG surgery patients2022-07-01 to 2025-06-30 | Not Available | 2.108 | |||
| Death rate for COPD patients2022-07-01 to 2025-06-30 | Not Available | 7.486 | |||
| Death rate for heart failure patients2022-07-01 to 2025-06-30 | Not Available | 9.785 | |||
| Death rate for pneumonia patients2022-07-01 to 2025-06-30 | Not Available | 13.44 | |||
| Death rate for stroke patients2023-07-01 to 2025-06-30 | Not Available | 11.76 | |||
| Pressure ulcer rate2022-07-01 to 2024-06-30 · 446 cases | 0.39 | 0.51 | 0.6721 | No Different Than the National Rate | Better than 68% of US hospitals |
| Death rate among surgical inpatients with serious treatable complications2022-07-01 to 2024-06-30 | Not Available | 175 | Number of Cases Too Small | ||
| Iatrogenic pneumothorax rate2022-07-01 to 2024-06-30 · 727 cases | 0.2 | 0.2 | 0.2083 | No Different Than the National Rate | Better than 46% of US hospitals |
| In-hospital fall-associated fracture rate2022-07-01 to 2024-06-30 · 739 cases | 0.26 | 0.27 | 0.296 | No Different Than the National Rate | Better than 54% of US hospitals |
| Postoperative hemorrhage or hematoma rate2022-07-01 to 2024-06-30 · 544 cases | 4.95 | 2.29 | 2.482 | Worse Than the National Rate | Worse than 99% of US hospitals |
| Postoperative acute kidney injury requiring dialysis rate2022-07-01 to 2024-06-30 · 413 cases | 1.55 | 1.63 | 1.613 | No Different Than the National Rate | Better than 73% of US hospitals |
| Postoperative respiratory failure rate2022-07-01 to 2024-06-30 · 180 cases | 7.3 | 8.88 | 9.192 | No Different Than the National Rate | Better than 81% of US hospitals |
| Perioperative pulmonary embolism or deep vein thrombosis rate2022-07-01 to 2024-06-30 · 581 cases | 2.96 | 3.4 | 3.743 | No Different Than the National Rate | Better than 82% of US hospitals |
| Postoperative sepsis rate2022-07-01 to 2024-06-30 · 409 cases | 3.79 | 5.105 | 5.331 | No Different Than the National Rate | Better than 95% of US hospitals |
| Postoperative wound dehiscence rate2022-07-01 to 2024-06-30 | Not Available | 1.756 | Number of Cases Too Small | ||
| Abdominopelvic accidental puncture or laceration rate2022-07-01 to 2024-06-30 · 100 cases | 1.03 | 1.02 | 1.044 | No Different Than the National Rate | Worse than 52% of US hospitals |
Unplanned returns to a hospital after a stay or an outpatient procedure; lower is better.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Hospital return days for heart attack patients2022-07-01 to 2025-06-30 | Not Available | 18.16 | |||
| Hospital return days for heart failure patients2022-07-01 to 2025-06-30 | Not Available | 17.34 | |||
| Hospital return days for pneumonia patients2022-07-01 to 2025-06-30 | Not Available | 17.01 | |||
| Hybrid Hospital-Wide All-Cause Readmission Measure (HWR)2024-07-01 to 2025-06-30 | Not Available | ||||
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)2022-01-01 to 2024-12-31 | Not Available | 12.66 | |||
| Rate of inpatient admissions for patients receiving outpatient chemotherapy2024-01-01 to 2024-12-31 · 27 cases | 10.2 | 10.7 | 10.92 | No Different Than the National Rate | Better than 64% of US hospitals |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy2024-01-01 to 2024-12-31 · 27 cases | 5.7 | 5.3 | 5.182 | No Different Than the National Rate | Worse than 69% of US hospitals |
| Ratio of unplanned hospital visits after hospital outpatient surgery2024-01-01 to 2024-12-31 · 692 cases | 0.9 | 1 | 0.9596 | No Different than expected | Better than 68% of US hospitals |
| Acute Myocardial Infarction (AMI) 30-Day Readmission Rate2023-07-01 to 2025-06-30 | Not Available | 14.76 | |||
| Rate of readmission for CABG2023-07-01 to 2025-06-30 | Not Available | 10.82 | |||
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patients2023-07-01 to 2025-06-30 | Not Available | 20.36 | |||
| Heart failure (HF) 30-Day Readmission Rate2023-07-01 to 2025-06-30 | Not Available | 22.03 | |||
| Rate of readmission after hip/knee replacement2023-07-01 to 2025-06-30 | Not Available | 5.709 | |||
| Pneumonia (PN) 30-Day Readmission Rate2023-07-01 to 2025-06-30 | Not Available | 17.81 |
Standardized infection ratios (1 is the US baseline) and the counts behind them; lower is better.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Central Line Associated Bloodstream Infection (ICU + select Wards): Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.2107 | |||
| Central Line Associated Bloodstream Infection (ICU + select Wards): Upper Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 1.812 | |||
| Central Line Associated Bloodstream Infection: Number of Device Days2024-10-01 to 2025-09-30 | 546 | 1,370 | 8,303 | ||
| Central Line Associated Bloodstream Infection (ICU + select Wards): Predicted Cases2024-10-01 to 2025-09-30 | 0.378 | 0.9835 | 8.287 | ||
| Central Line Associated Bloodstream Infection (ICU + select Wards): Observed Cases2024-10-01 to 2025-09-30 | 0 | 0 | 4.273 | ||
| Central Line Associated Bloodstream Infection (ICU + select Wards)2024-10-01 to 2025-09-30 | Not Available | 0.4759 | |||
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.2845 | |||
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Upper Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 1.932 | |||
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Number of Urinary Catheter Days2024-10-01 to 2025-09-30 | 654 | 1,799 | 7,314 | ||
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Predicted Cases2024-10-01 to 2025-09-30 | 0.39 | 1.377 | 8.986 | ||
| Catheter Associated Urinary Tract Infections (ICU + select Wards): Observed Cases2024-10-01 to 2025-09-30 | 0 | 0 | 5.818 | ||
| Catheter Associated Urinary Tract Infections (ICU + select Wards)2024-10-01 to 2025-09-30 | Not Available | 0.6647 | |||
| SSI - Colon Surgery: Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.3618 | |||
| SSI - Colon Surgery: Upper Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 2.379 | |||
| SSI - Colon Surgery: Number of Procedures2024-10-01 to 2025-09-30 | Not Available | 149 | |||
| SSI - Colon Surgery: Predicted Cases2024-10-01 to 2025-09-30 | Not Available | 3.928 | |||
| SSI - Colon Surgery: Observed Cases2024-10-01 to 2025-09-30 | Not Available | 3.531 | |||
| SSI - Colon Surgery2024-10-01 to 2025-09-30 | Not Available | 0.7845 | |||
| SSI - Abdominal Hysterectomy: Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.4656 | |||
| SSI - Abdominal Hysterectomy: Upper Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 3.886 | |||
| SSI - Abdominal Hysterectomy: Number of Procedures2024-10-01 to 2025-09-30 | Not Available | 72.32 | |||
| SSI - Abdominal Hysterectomy: Predicted Cases2024-10-01 to 2025-09-30 | Not Available | 0.6066 | |||
| SSI - Abdominal Hysterectomy: Observed Cases2024-10-01 to 2025-09-30 | Not Available | 0.7955 | |||
| SSI - Abdominal Hysterectomy2024-10-01 to 2025-09-30 | Not Available | 1.451 | |||
| MRSA Bacteremia: Lower Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 0.2428 | |||
| MRSA Bacteremia: Upper Confidence Limit2024-10-01 to 2025-09-30 | Not Available | 2.383 | |||
| MRSA Bacteremia: Patient Days2024-10-01 to 2025-09-30 | 8,909 | 14,451 | 69,453 | ||
| MRSA Bacteremia: Predicted Cases2024-10-01 to 2025-09-30 | 0.184 | 0.567 | 4.799 | ||
| MRSA Bacteremia: Observed Cases2024-10-01 to 2025-09-30 | 0 | 0 | 3.018 | ||
| MRSA Bacteremia2024-10-01 to 2025-09-30 | Not Available | 0.6915 | |||
| Clostridium Difficile (C.Diff): Lower Confidence Limit2024-10-01 to 2025-09-30 | 0.03 | 0.127 | 0.2286 | No Different than National Benchmark | |
| Clostridium Difficile (C.Diff): Upper Confidence Limit2024-10-01 to 2025-09-30 | 2.925 | 0.747 | 0.9902 | No Different than National Benchmark | |
| Clostridium Difficile (C.Diff): Patient Days2024-10-01 to 2025-09-30 | 8,909 | 13,646 | 64,881 | No Different than National Benchmark | |
| Clostridium Difficile (C.Diff): Predicted Cases2024-10-01 to 2025-09-30 | 1.686 | 5.683 | 33.9 | No Different than National Benchmark | |
| Clostridium Difficile (C.Diff): Observed Cases2024-10-01 to 2025-09-30 | 1 | 2 | 16.5 | No Different than National Benchmark | |
| Clostridium Difficile (C.Diff)2024-10-01 to 2025-09-30 | 0.593 | 0.279 | 0.4375 | No Different than National Benchmark | Worse than 82% of US hospitals |
How recent inpatients answered each survey question, with CMS's star rating per topic.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Room was "always" clean2024-10-01 to 2025-09-30 · 351 cases | 75 | 73 | 69.54 | Better than 56% of US hospitals | |
| Room was "sometimes" or "never" clean2024-10-01 to 2025-09-30 · 351 cases | 7 | 8 | 10.27 | Better than 56% of US hospitals | |
| Room was "usually" clean2024-10-01 to 2025-09-30 · 351 cases | 18 | 18 | 20.2 | ||
| Cleanliness - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 89 | 87 | 85.15 | Better than 66% of US hospitals | |
| Cleanliness - star rating2024-10-01 to 2025-09-30 · 351 cases | 4 | 4 | 3.13 | Better than 47% of US hospitals | |
| Nurses "always" communicated well2024-10-01 to 2025-09-30 · 351 cases | 81 | 80 | 79.3 | Better than 56% of US hospitals | |
| Nurse communication - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 93 | 91 | 91.43 | Better than 69% of US hospitals | |
| Nurses "sometimes" or "never" communicated well2024-10-01 to 2025-09-30 · 351 cases | 3 | 4 | 4.75 | Better than 58% of US hospitals | |
| Nurse communication - star rating2024-10-01 to 2025-09-30 · 351 cases | 4 | 3 | 3.463 | Better than 51% of US hospitals | |
| Nurses "usually" communicated well2024-10-01 to 2025-09-30 · 351 cases | 16 | 16 | 15.95 | ||
| Doctors "always" communicated well2024-10-01 to 2025-09-30 · 351 cases | 79 | 79 | 78.45 | Worse than 47% of US hospitals | |
| Doctor communication - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 91 | 91 | 90.5 | Better than 45% of US hospitals | |
| Doctors "sometimes" or "never" communicated well2024-10-01 to 2025-09-30 · 351 cases | 6 | 5 | 5.893 | Worse than 56% of US hospitals | |
| Doctor communication - star rating2024-10-01 to 2025-09-30 · 351 cases | 3 | 3 | 3.019 | Worse than 37% of US hospitals | |
| Doctors "usually" communicated well2024-10-01 to 2025-09-30 · 351 cases | 15 | 16 | 15.66 | ||
| Staff "always" explained2024-10-01 to 2025-09-30 · 351 cases | 64 | 61 | 60.82 | Better than 64% of US hospitals | |
| Communication about medicines - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 81 | 77 | 76.96 | Better than 79% of US hospitals | |
| Staff "sometimes" or "never" explained2024-10-01 to 2025-09-30 · 351 cases | 15 | 19 | 19.86 | Better than 74% of US hospitals | |
| Communication about medicines - star rating2024-10-01 to 2025-09-30 · 351 cases | 4 | 3 | 2.704 | Better than 79% of US hospitals | |
| Staff "usually" explained2024-10-01 to 2025-09-30 · 351 cases | 21 | 19 | 19.32 | ||
| Discharge information - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 88 | 86 | 86.83 | Better than 68% of US hospitals | |
| No, staff "did not" give patients this information2024-10-01 to 2025-09-30 · 351 cases | 11 | 13 | 12.75 | Better than 68% of US hospitals | |
| Discharge information - star rating2024-10-01 to 2025-09-30 · 351 cases | 4 | 3 | 3.648 | Better than 55% of US hospitals | |
| Yes, staff "did" give patients this information2024-10-01 to 2025-09-30 · 351 cases | 89 | 87 | 87.25 | Better than 68% of US hospitals | |
| No, staff "did not" give patients information about help after discharge2024-10-01 to 2025-09-30 · 351 cases | 15 | 14 | 13.96 | Worse than 51% of US hospitals | |
| Yes, staff "did" give patients information about help after discharge2024-10-01 to 2025-09-30 · 351 cases | 85 | 86 | 86.04 | Worse than 51% of US hospitals | |
| Doctors "always" explained things so they could understand2024-10-01 to 2025-09-30 · 351 cases | 74 | 74 | 73.88 | Better than 48% of US hospitals | |
| Doctors "sometimes" or "never" explained things so they could understand2024-10-01 to 2025-09-30 · 351 cases | 7 | 7 | 7.232 | Worse than 47% of US hospitals | |
| Doctors "usually" explained things so they could understand2024-10-01 to 2025-09-30 · 351 cases | 19 | 19 | 18.89 | ||
| Doctors "always" listened carefully2024-10-01 to 2025-09-30 · 351 cases | 77 | 77 | 76.98 | Worse than 49% of US hospitals | |
| Doctors "sometimes" or "never" listened carefully2024-10-01 to 2025-09-30 · 351 cases | 6 | 6 | 6.357 | Worse than 47% of US hospitals | |
| Doctors "usually" listened carefully2024-10-01 to 2025-09-30 · 351 cases | 17 | 17 | 16.66 | ||
| Doctors "always" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 351 cases | 86 | 85 | 84.46 | Better than 53% of US hospitals | |
| Doctors "sometimes" or "never" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 351 cases | 3 | 3 | 4.036 | Better than 49% of US hospitals | |
| Doctors "usually" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 351 cases | 11 | 11 | 11.5 | ||
| Patients who gave a rating of "6" or lower (low)2024-10-01 to 2025-09-30 · 351 cases | 7 | 8 | 9.911 | Better than 52% of US hospitals | |
| Patients who gave a rating of "7" or "8" (medium)2024-10-01 to 2025-09-30 · 351 cases | 15 | 20 | 22.54 | ||
| Patients who gave a rating of "9" or "10" (high)2024-10-01 to 2025-09-30 · 351 cases | 78 | 72 | 67.55 | Better than 74% of US hospitals | |
| Overall hospital rating - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 91 | 88 | 86.72 | Better than 77% of US hospitals | |
| Overall hospital rating - star rating2024-10-01 to 2025-09-30 · 351 cases | 4 | 3 | 2.981 | Better than 55% of US hospitals | |
| Staff "always" explained new medications2024-10-01 to 2025-09-30 · 351 cases | 77 | 74 | 74.29 | Better than 66% of US hospitals | |
| Staff "sometimes" or "never" explained new medications2024-10-01 to 2025-09-30 · 351 cases | 8 | 9 | 9.679 | Better than 60% of US hospitals | |
| Staff "usually" explained new medications2024-10-01 to 2025-09-30 · 351 cases | 15 | 16 | 16.04 | ||
| Nurses "always" explained things so they could understand2024-10-01 to 2025-09-30 · 351 cases | 77 | 75 | 75.66 | Better than 63% of US hospitals | |
| Nurses "sometimes" or "never" explained things so they could understand2024-10-01 to 2025-09-30 · 351 cases | 5 | 5 | 6.125 | Better than 49% of US hospitals | |
| Nurses "usually" explained things so they could understand2024-10-01 to 2025-09-30 · 351 cases | 18 | 20 | 18.21 | ||
| Nurses "always" listened carefully2024-10-01 to 2025-09-30 · 351 cases | 78 | 77 | 77 | Better than 56% of US hospitals | |
| Nurses "sometimes" or "never" listened carefully2024-10-01 to 2025-09-30 · 351 cases | 3 | 4 | 4.946 | Better than 64% of US hospitals | |
| Nurses "usually" listened carefully2024-10-01 to 2025-09-30 · 351 cases | 19 | 19 | 18.05 | ||
| Nurses "always" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 351 cases | 87 | 86 | 85.23 | Better than 53% of US hospitals | |
| Nurses "sometimes" or "never" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 351 cases | 2 | 3 | 3.125 | Better than 50% of US hospitals | |
| Nurses "usually" treated them with courtesy and respect2024-10-01 to 2025-09-30 · 351 cases | 11 | 11 | 11.64 | ||
| "Always" quiet at night2024-10-01 to 2025-09-30 · 351 cases | 50 | 59 | 47.63 | Worse than 80% of US hospitals | |
| "Sometimes" or "never" quiet at night2024-10-01 to 2025-09-30 · 351 cases | 17 | 9 | 17.7 | Worse than 85% of US hospitals | |
| "Usually" quiet at night2024-10-01 to 2025-09-30 · 351 cases | 33 | 31 | 34.68 | ||
| Quietness - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 75 | 82 | 74.48 | Worse than 84% of US hospitals | |
| Quietness - star rating2024-10-01 to 2025-09-30 · 351 cases | 2 | 3 | 2.111 | Worse than 76% of US hospitals | |
| "NO", patients would not recommend the hospital (they probably would not or definitely would not recommend it)2024-10-01 to 2025-09-30 · 351 cases | 3 | 5 | 6.143 | Better than 70% of US hospitals | |
| "YES", patients would definitely recommend the hospital2024-10-01 to 2025-09-30 · 351 cases | 83 | 71 | 69.48 | Better than 87% of US hospitals | |
| Recommend hospital - linear mean score2024-10-01 to 2025-09-30 · 351 cases | 93 | 87 | 86.65 | Better than 90% of US hospitals | |
| "YES", patients would probably recommend the hospital2024-10-01 to 2025-09-30 · 351 cases | 14 | 23 | 24.38 | ||
| Recommend hospital - star rating2024-10-01 to 2025-09-30 · 351 cases | 5 | 4 | 3.556 | The top rating, shared by 24% of US hospitals | |
| Staff "always" explained possible side effects2024-10-01 to 2025-09-30 · 351 cases | 52 | 47 | 47.23 | Better than 72% of US hospitals | |
| Staff "sometimes" or "never" explained possible side effects2024-10-01 to 2025-09-30 · 351 cases | 22 | 30 | 30.13 | Better than 84% of US hospitals | |
| Staff "usually" explained possible side effects2024-10-01 to 2025-09-30 · 351 cases | 26 | 22 | 22.64 | ||
| Summary star rating2024-10-01 to 2025-09-30 · 351 cases | 4 | 3 | 3.056 | Better than 60% of US hospitals | |
| No, staff "did not" give patients information about possible symptoms2024-10-01 to 2025-09-30 · 351 cases | 8 | 12 | 11.66 | Better than 87% of US hospitals | |
| Yes, staff "did" give patients information about possible symptoms2024-10-01 to 2025-09-30 · 351 cases | 92 | 88 | 88.34 | Better than 87% of US hospitals |
How often the hospital gave recommended care, and how fast.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Emergency department volume2024-01-01 to 2024-12-31 | medium | ||||
| Global Malnutrition Composite Score2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Malnutrition Diagnosis Documented2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Malnutrition Risk Screening2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Nutrition Assessment2024-01-01 to 2024-12-31 | Not Available | ||||
| Global Malnutrition Composite Score: Nutritional Care Plan2024-01-01 to 2024-12-31 | Not Available | ||||
| Hospital Harm - Severe Hyperglycemia2024-01-01 to 2024-12-31 | Not Available | 9 | |||
| Hospital Harm - Severe Hypoglycemia2024-01-01 to 2024-12-31 | Not Available | 1.188 | |||
| Hospital Harm - Opioid Related Adverse Events2024-01-01 to 2024-12-31 | Not Available | 0 | |||
| Healthcare workers given influenza vaccination2024-10-01 to 2025-03-31 · 3,740 cases | 98 | 79 | 84.05 | Better than 96% of US hospitals | |
| Average (median) time all patients spent in the emergency department before leaving from the visit, including psychiatric/mental health patients and patients who were transferred to another facility. A lower number of minutes is better2024-10-01 to 2025-09-30 · 406 cases | 174 | 154 | 227 | Worse than 63% of US hospitals | |
| Average (median) time patients spent in the emergency department before leaving from the visit, excluding patients transferred to another facility or psychiatric care/mental health patients. A lower number of minutes is better2024-10-01 to 2025-09-30 · 397 cases | 174 | 148 | 219 | Worse than 67% of US hospitals | |
| Average (median) time psychiatric/mental health patients spent in the emergency department before leaving from the visit. A lower number of minutes is better2024-10-01 to 2025-09-30 | Not Available | 381 | |||
| Average (median) time patients spent in the emergency department before being transferred to another facility. A lower number of minutes is better2024-10-01 to 2025-09-30 | Not Available | 358 | |||
| Left before being seen2024-01-01 to 2024-12-31 · 33,439 cases | 3 | 1 | 3.981 | Worse than 78% of US hospitals | |
| Head CT results2024-10-01 to 2025-09-30 | Not Available | 69.39 | |||
| Endoscopy/polyp surveillance: appropriate follow-up interval for normal colonoscopy in average risk patients2024-01-01 to 2024-12-31 | Not Available | 97.12 | |||
| Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery2024-01-01 to 2024-12-31 | Not Available | ||||
| ST-Segment Elevation Myocardial Infarction (STEMI)2024-01-01 to 2024-12-31 | Not Available | 30.67 | |||
| Safe Use of Opioids - Concurrent Prescribing2024-01-01 to 2024-12-31 · 277 cases | 16 | 15 | 17.23 | Worse than 57% of US hospitals | |
| Appropriate care for severe sepsis and septic shock2024-10-01 to 2025-09-30 | Not Available | 53.88 | |||
| Septic Shock 3-Hour Bundle2024-10-01 to 2025-09-30 | Not Available | 63.72 | |||
| Septic Shock 6-Hour Bundle2024-10-01 to 2025-09-30 | Not Available | 81.64 | |||
| Severe Sepsis 3-Hour Bundle2024-10-01 to 2025-09-30 | Not Available | 74.82 | |||
| Severe Sepsis 6-Hour Bundle2024-10-01 to 2025-09-30 | Not Available | 90.31 | |||
| Discharged on Antithrombotic Therapy2024-01-01 to 2024-12-31 | Not Available | 97.42 | |||
| Anticoagulation Therapy for Atrial Fibrillation/Flutter2024-01-01 to 2024-12-31 | Not Available | 81 | |||
| Antithrombotic Therapy by End of Hospital Day 22024-01-01 to 2024-12-31 | Not Available | 93 | |||
| Venous Thromboembolism Prophylaxis2024-01-01 to 2024-12-31 · 1,018 cases | 93 | 90 | 91.36 | Better than 60% of US hospitals | |
| Intensive Care Unit Venous Thromboembolism Prophylaxis2024-01-01 to 2024-12-31 | Not Available | 96.17 |
How often scans were ordered when they may not be needed; lower is better.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Abdomen CT Use of Contrast Material2024-07-01 to 2025-06-30 | 0 | 5 | 4.356 | The best result, shared by 2% of US hospitals | |
| Breast Cancer Screening Recall Rates2024-07-01 to 2025-06-30 | Not Available | 6.335 |
Medicare spending around an inpatient stay compared with the US (1 is the US median).
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| Medicare hospital spending per patient (Medicare Spending per Beneficiary)2024-01-01 to 2024-12-31 | 0.96 | 0.99 | 0.9783 | Better than 63% of US hospitals |
Excess readmission ratios by condition; above 1 means more readmissions than expected.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| READM-30-AMI-HRRP2021-07-01 to 2024-06-30 | N/A | 1.051 | |||
| READM-30-CABG-HRRP2021-07-01 to 2024-06-30 | N/A | 1.024 | |||
| READM-30-COPD-HRRP2021-07-01 to 2024-06-30 | N/A | 1.036 | |||
| READM-30-HF-HRRP2021-07-01 to 2024-06-30 | N/A | 1.036 | |||
| READM-30-HIP-KNEE-HRRP2021-07-01 to 2024-06-30 | N/A | 1.008 | |||
| READM-30-PN-HRRP2021-07-01 to 2024-06-30 | N/A | 1.046 |
| By fiscal year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|
| READM-30-AMI-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
| READM-30-CABG-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
| READM-30-COPD-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
| READM-30-HF-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
| READM-30-HIP-KNEE-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
| READM-30-PN-HRRP | N/A | N/A | N/A | N/A | N/A | N/A |
Infection ratios, the PSI 90 composite and the total score Medicare ranks hospitals on; lower is better.
| Measure | Mass Eye & Ear Infirmary | US median | MA average | CMS comparison | US rank |
|---|---|---|---|---|---|
| CAUTI standardized infection ratio2023-01-01 to 2024-12-31 | N/A | 0.7646 | |||
| CDI standardized infection ratio2023-01-01 to 2024-12-31 | 0.994 | 0.346 | 0.4801 | Worse than 96% of US hospitals | |
| CLABSI standardized infection ratio2023-01-01 to 2024-12-31 | N/A | 0.683 | |||
| HAC Reduction Program payment reductionFY 2026 | Yes | ||||
| MRSA standardized infection ratio2023-01-01 to 2024-12-31 | N/A | 0.6605 | |||
| Patient safety and adverse events composite (PSI 90)2022-07-01 to 2024-06-30 | 0.8336 | 0.9628 | 1.026 | Better than 89% of US hospitals | |
| SSI standardized infection ratio2023-01-01 to 2024-12-31 | N/A | 0.9399 | |||
| Total HAC scoreFY 2026 | 1.095 | -0.0453 | 0.2232 | Worse than 96% of US hospitals |
| By fiscal year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|
| HAC Reduction Program payment reduction | Yes | Yes | N/A | Yes | Yes | Yes |
| Total HAC score | 0.4049 | 0.6176 | 0 | 0.8001 | 0.6546 | 1.095 |
Source: CMS Care Compare hospital files, latest release 2026-09-30, with program results for earlier fiscal years from CMS's archived snapshots. US medians and ranks count every hospital CMS reports; state averages are plain means of the state's reporting hospitals, not CMS's patient-weighted state rates.
The Joint Commission (since 2011)
Accreditation
Major
Medical school affiliation
Private (not for profit)
Ownership type
42
Medicare-certified beds
125
Registered nurses (full-time equivalent)
1966
In Medicare since
Source: CMS Provider of Services file, as reported by the hospital and state surveyors.
What Mass Eye & Ear Infirmary reported to Medicare in its latest cost report, covering Oct 1, 2024 to Sep 30, 2025.
1,553
Inpatient discharges
Medicare 26%, Medicaid n/a
6,244
Inpatient days
42% of available bed days used
1,569
Employees (full-time equivalent)
37
Interns and residents (full-time equivalent)
Source: CMS cost report (HCRIS) (report 831166). Figures cover the reporting period, which is not always 12 months, and are self-reported.
Inpatient days and discharges Mass Eye & Ear Infirmary reported by payer. Medicare and Medicaid include their managed care plans, shown separately below.
| Medicare | Medicaid | Other | Total | |
|---|---|---|---|---|
| Inpatient days | 1,755 | 377 | 4,112 | 6,244 |
| Discharges | 402 | 0 | 1,151 | 1,553 |
| Average length of stay | 4.4 days | 3.6 days | 4.0 days | |
| Average daily census | 4.8 | 1.0 | 11.3 | 17.1 |
907
Medicare Advantage days
172 discharges
843
Medicaid managed care days
886
Observation bed days
| Unit | Beds | Inpatient days | Medicare days | Occupancy |
|---|---|---|---|---|
| Adults & pediatrics | 41 | 6,244 | 1,755 | 42% |
Source: CMS cost report (HCRIS, Form 2552-10), report 831166, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Worksheet S-3 Part I.
What Mass Eye & Ear Infirmary treats Medicare patients for most often, in 2024. 159 Medicare discharges in 8 published DRGs; 93% surgical; 72% in DRGs with complications (CC or MCC).
| Condition or procedure | Discharges | Average charges | Average Medicare payment | Estimated cost | DRG weight |
|---|---|---|---|---|---|
| Major head and neck procedures with CCMS-DRG 141, surgical | 37 | $71,316 | $23,710 | $35,729 | 2.07 |
| Major male pelvic procedures without cc/mccMS-DRG 708, surgical | 26 | $40,466 | $16,016 | $20,273 | 1.46 |
| Tracheostomy for face, mouth and neck diagnoses or laryngectomy with CCMS-DRG 012, surgical | 24 | $110,272 | $40,055 | $55,246 | 4.00 |
| Major head and neck procedures without cc/mccMS-DRG 142, surgical | 18 | $43,332 | $17,872 | $21,709 | 1.54 |
| Other ear, nose, mouth and throat o.r. procedures with CCMS-DRG 144, surgical | 17 | $54,101 | $19,551 | $27,105 | 1.73 |
| Intraocular procedures with cc/mccMS-DRG 116, surgical | 15 | $37,392 | $20,158 | $18,733 | 1.83 |
| Tracheostomy for face, mouth and neck diagnoses or laryngectomy with MCCMS-DRG 011, surgical | 11 | $119,075 | $50,794 | $59,656 | 5.16 |
| Ear, nose, mouth and throat malignancy with CCMS-DRG 147, medical | 11 | $33,837 | $14,946 | $16,952 | 1.24 |
Source: CMS Medicare Inpatient Hospitals by Provider and Service (2024 data, released 2026-04-10), traditional Medicare only; CMS omits DRGs with fewer than 11 discharges. Estimated cost is average charges times the hospital's Medicare cost-to-charge ratio from the IPPS Impact File. Weights are the MS-DRG relative weights for the same year.
The comprehensive outpatient service groups (APCs) Mass Eye & Ear Infirmary billed Medicare for most in 2024: 7,881 services in all.
| Service group | Services | Patients | Average charges | Average Medicare payment | US average payment |
|---|---|---|---|---|---|
| Level 1 Intraocular ProceduresAPC 5491 | 3,528 | 2,533 | $6,200 | $1,979 | $1,752 |
| Level 2 Intraocular ProceduresAPC 5492 | 1,036 | 935 | $10,943 | $3,452 | $3,116 |
| Level 3 Airway EndoscopyAPC 5153 | 733 | 501 | $4,319 | $1,441 | $1,264 |
| Level 3 Extraocular, Repair, and Plastic Eye ProceduresAPC 5503 | 711 | 663 | $7,558 | $1,987 | $1,780 |
| Level 5 ENT ProceduresAPC 5165 | 291 | 285 | $19,112 | $5,010 | $4,436 |
| Level 4 Airway EndoscopyAPC 5154 | 262 | 202 | $8,199 | $3,161 | $2,833 |
| Level 3 Intraocular ProceduresAPC 5493 | 246 | 208 | $13,498 | $4,472 | $4,004 |
| Level 3 ENT ProceduresAPC 5163 | 230 | 116 | $3,465 | $1,293 | $1,106 |
| Level 5 Airway EndoscopyAPC 5155 | 204 | 200 | $17,199 | $5,742 | $5,183 |
| Level 4 Extraocular, Repair, and Plastic Eye ProceduresAPC 5504 | 119 | 114 | $12,597 | $3,307 | $2,969 |
See all 18 Medicare outpatient services at Mass Eye & Ear Infirmary
Source: CMS Medicare Outpatient Hospitals by Provider and Service (2024 data, released 2026-06-24), comprehensive APCs for traditional Medicare; CMS omits services with fewer than 11 claims. The US average weights every hospital by its services.
ZIP codes with the most Medicare inpatient stays at Mass Eye & Ear Infirmary in 2025. Market share is this hospital's part of every hospital's Medicare stays from the ZIP code. Its published Medicare stays went from 11 in 2022 to 11 in 2025.
| ZIP code | Stays | Of this hospital's stays | Days | Charges | Market share |
|---|---|---|---|---|---|
| 01930 | 11 | 100% | 40 | $607,074 | 0% |
Source: CMS Hospital Service Area file. Shares are of the 11 stays from ZIP codes CMS publishes; it omits ZIP codes with fewer than 11 stays, so market shares count published stays only.
Staff by profession and the rooms and units Mass Eye & Ear Infirmary reported at its latest Medicare certification survey (1993). Counts are people, not full-time equivalents.
125
Registered nurses
11
Licensed practical nurses
42
Resident physicians
16
Nurse anesthetists (CRNAs)
6
Pharmacists
2
Speech pathologists and audiologists
1
Dietitians
5
Social workers
970
Other personnel
Source: CMS Provider of Services file.
1,012 clinicians who bill Medicare list Mass Eye & Ear Infirmary as a hospital affiliation. Showing 24 of them. Book a demo to see the commercial rates insurers publish for them, or start a free trial.
David Reed, M.D.
Retina Specialist (Ophthalmology) Physician
NPI 1932330990
See commercial rates for David Reed, M.D.Babak Jian Seyedahmadi, M.D.
Ophthalmology Physician
NPI 1538262761
See commercial rates for Babak Jian Seyedahmadi, M.D.Jeffrey Heier
Retina Specialist (Ophthalmology) Physician
NPI 1578546917
See commercial rates for Jeffrey HeierMiriam Englander-Paschalis Ilios, M.D.
Retina Specialist (Ophthalmology) Physician
NPI 1184853129
See commercial rates for Miriam Englander-Paschalis Ilios, M.D.Tina Cleary
Retina Specialist (Ophthalmology) Physician
NPI 1649243221
See commercial rates for Tina ClearyAdam Chin, M.D.
Ophthalmology Physician
NPI 1992192884
See commercial rates for Adam Chin, M.D.Peter Chang, M.D.
Ophthalmology Physician
NPI 1801107859
See commercial rates for Peter Chang, M.D.James Stefater, MD, PHD
Ophthalmology Physician
NPI 1427491000
See commercial rates for James Stefater, MD, PHDMark Dacey, M.D.
Ophthalmology Physician
NPI 1184613192
See commercial rates for Mark Dacey, M.D.Albert Liao, MD, MS
Ophthalmology Physician
NPI 1801390216
See commercial rates for Albert Liao, MD, MSCatherine Tang
Endocrinology, Diabetes & Metabolism Physician
NPI 1972869477
See commercial rates for Catherine TangTheresa Hadlock, M.D.
Facial Plastic Surgery Physician
NPI 1578554549
See commercial rates for Theresa Hadlock, M.D.Eddie Kadrmas, M.D.
Ophthalmology Physician
NPI 1124097241
See commercial rates for Eddie Kadrmas, M.D.Karen Jeng-Miller, MD
Ophthalmology Physician
NPI 1720460447
See commercial rates for Karen Jeng-Miller, MDAndre Witkin, M.D.
Retina Specialist (Ophthalmology) Physician
NPI 1285811216
See commercial rates for Andre Witkin, M.D.Stephen Anesi, M.D.
Ophthalmology Physician
NPI 1003052788
See commercial rates for Stephen Anesi, M.D.Namrata Nandakumar, MD
Ophthalmology Physician
NPI 1932364817
See commercial rates for Namrata Nandakumar, MDRyan Chung, M.D.
Diagnostic Radiology Physician
NPI 1417342809
See commercial rates for Ryan Chung, M.D.Kameran Lashkari, M.D.
Ophthalmology Physician
NPI 1710973425
See commercial rates for Kameran Lashkari, M.D.Matthew Wszolek, M.D.
Urology Physician
NPI 1740470889
See commercial rates for Matthew Wszolek, M.D.Tobin Abraham, M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI 1568629376
See commercial rates for Tobin Abraham, M.D.Mehnaz Khan, M.D.
Ophthalmology Physician
NPI 1740575067
See commercial rates for Mehnaz Khan, M.D.Michael Blake, MD
Diagnostic Radiology Physician
NPI 1871583039
See commercial rates for Michael Blake, MDAnne Kushwaha, M.D.
Diagnostic Radiology Physician
NPI 1134121742
See commercial rates for Anne Kushwaha, M.D.Source: CMS Doctors and Clinicians facility affiliations, released 2026-10-15, with names and specialties from NPPES. Affiliation means the clinician bills Medicare for care at this hospital; it is not employment.
Revenue, expenses and income Mass Eye & Ear Infirmary reported to Medicare for Oct 1, 2024 to Sep 30, 2025. Percentages are of net patient revenue.
| Line | Amount | Share |
|---|---|---|
| Gross patient revenue (charges) | $786.1M | 226.3% |
| Inpatient | $72.2M | 20.8% |
| Outpatient | $713.9M | 205.6% |
| Contractual allowances and discounts | -$438.8M | -126.3% |
| Net patient revenue | $347.3M | 100.0% |
| Operating expenses | -$457.3M | -131.7% |
| Operating income from patient care | -$110M | -31.7% |
| Other income | $122.3M | 35.2% |
| Net income | $12.3M | 3.6% |
| Line | Amount | Share |
|---|---|---|
| Traditional Medicare | $190M | 24.2% |
| Medicaid (including managed care) | $77.6M | 9.9% |
| Other payers and self-pay | $518.4M | 66.0% |
| Total charges | $786.1M | 100.0% |
Source: CMS cost report (HCRIS, Form 2552-10), report 831166, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Traditional Medicare is the program charges on Worksheets D-3 and D Part V; Medicaid is from Worksheet S-10.
Computed from Mass Eye & Ear Infirmary's latest cost report.
-31.7%
Operating margin
Operating income from patient care / net patient revenue
2.6%
Total margin
Net income / net patient revenue plus other income
10.6%
EBITDAR margin
Net income before interest, depreciation and leases (Worksheet A-7), / total revenue
37% of expenses
Personnel costs
Salaries, direct-care contract labor and core wage-related costs / operating expenses
$43.26
Average hourly wage
Adjusted salaries / paid hours (Worksheet S-3 Part II)
1.5%
Return on assets
Net income for a year / total assets
2.3%
Return on equity
Net income for a year / fund balance
0.20
Long-term debt to fund balance
Mortgages, notes and loans / fund balance
0.83
Current ratio
Current assets / current liabilities
0.15
Quick ratio
Cash, temporary investments and net receivables / current liabilities
-16 days
Days cash on hand
Cash and temporary investments / daily operating expenses excluding depreciation
36 days
Days in patient receivables
Net patient receivables / daily net patient revenue
89 days
Average payment period
Current liabilities / daily operating expenses excluding depreciation
0.58
Asset turnover
Total revenue for a year / total assets
10.5 years
Average age of plant
Accumulated depreciation / depreciation for a year
Source: CMS cost report (HCRIS, Form 2552-10), report 831166, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
What Mass Eye & Ear Infirmary owned and owed at the end of its reporting period (Sep 2025), across all fund types: $809.5M in total assets and a $542.5M fund balance.
| Line | Amount | Of total assets |
|---|---|---|
| Cash and temporary investments | -$19M | -2.4% |
| Patient receivables, net | $34.7M | 4.3% |
| Inventory | $2.2M | 0.3% |
| Total current assets | $87.1M | 10.8% |
| Property and equipment, net of depreciation | $181.4M | 22.4% |
| Investments and other assets | $541M | 66.8% |
| Total assets | $809.5M | 100.0% |
| Current liabilities | $105.3M | 13.0% |
| Long-term debt | $109.2M | 13.5% |
| Total liabilities | $267M | 33.0% |
| Fund balance (net assets) | $542.5M | 67.0% |
Source: CMS cost report (HCRIS, Form 2552-10), report 831166, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Care Mass Eye & Ear Infirmary provided without full payment, as reported on Worksheet S-10 of its cost report.
$3.9M
Cost of charity care
Care for patients approved for charity care and uninsured discounts, at cost
$8M
Bad debt
Patient bills written off as uncollectible, at charges
$4M
Medicaid shortfall
Cost of Medicaid patients (charges times the cost-to-charge ratio) minus Medicaid payments; negative means a surplus
$14.1M
Total unreimbursed and uncompensated care
3.1% of operating expenses
Medicaid, CHIP and indigent care shortfalls plus charity care and the cost of bad debt (Worksheet S-10 line 31)
-$722,893
Government grants and appropriations
Government grants or transfers supporting hospital operations
Source: CMS cost report (HCRIS, Form 2552-10), report 831166, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Mass Eye & Ear Infirmary's full-year cost reports, by fiscal year end. Reports shorter than ten months are left out.
| Fiscal year ending | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|
| Net patient revenue | $190.8M | $244.6M | $263.9M | $289.3M | $311.8M | $347.3M |
| Operating expenses | $323M | $348.5M | $359.2M | $400.8M | $432.4M | $457.3M |
| Operating margin | -69.3% | -42.5% | -36.1% | -38.5% | -38.7% | -31.7% |
| Net income | -$11.6M | $52.5M | $2.1M | -$1.4M | $1.3M | $12.3M |
| Total assets | $656.2M | $727.1M | $611.1M | $650.2M | $715.1M | $809.5M |
| Discharges | 1,047 | 1,033 | 1,075 | 1,127 | 1,555 | 1,553 |
| Inpatient days | 4,192 | 4,234 | 4,610 | 4,394 | 6,349 | 6,244 |
| Medicare Advantage days | 474 | 476 | 689 | 850 | 983 | 907 |
| Beds | 41 | 41 | 41 | 41 | 41 | 41 |
| Employees (FTE) | 808 | 880 | 869 | 1,259 | 1,357 | 1,569 |
Source: CMS cost report (HCRIS, Form 2552-10), report 831166, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Each cost center Mass Eye & Ear Infirmary reports, largest first. Total cost includes its share of overhead; the cost-to-charge ratio is total cost / charges.
| Department | Salaries | Total cost | Charges | Cost-to-charge | Square feet |
|---|---|---|---|---|---|
| Operating room | $21.6M | $71.8M | $255.8M | 0.28 | 32,004 |
| Clinic | $15M | $54.9M | $163.8M | 0.34 | 107,611 |
| Drugs charged to patients | $51.9M | $69.4M | 0.75 | ||
| Impl. dev. charged to patients | $24.1M | $36.9M | 0.65 | ||
| Recovery room | $6.7M | $15.5M | $14.9M | 1.04 | 16,175 |
| Medical supplies charged to patient | $14.5M | $10.1M | 1.43 | ||
| Emergency | $4M | $8.8M | $28.6M | 0.31 | 5,139 |
| Laboratory | $424,164 | $7.2M | $44.8M | 0.16 | 4,872 |
| Radiology-diagnostic | $2.1M | $5.8M | $10.3M | 0.57 | 7,900 |
| Anesthesiology | $1.7M | $4.8M | $54.9M | 0.09 | 3,262 |
| Asc (non-distinct part) | $1.3M | $4.4M | $8.8M | 0.49 | 2,441 |
| Mri | $1.7M | $4.1M | $36.5M | 0.11 | 2,339 |
| Observation beds (non-distinct part | $3.6M | $2.7M | 1.35 | ||
| Ct scan | $863,433 | $2.4M | $24.9M | 0.10 | 958 |
| Hyperbaric oxygen therapy | $457,142 | $569,957 | $3.5M | 0.16 | 830 |
| Respiratory therapy | $131,829 | $259,498 | $8,899 | 29.16 | |
| Blood storing processing & trans. | $219,983 | $84,916 | 2.59 | ||
| Physical therapy | $171,808 | $241,964 | 0.71 | ||
| Occupational therapy | $57,132 | $237,932 | 0.24 |
| Department | Salaries | Total cost | Charges | Cost-to-charge | Square feet |
|---|---|---|---|---|---|
| Adults & pediatrics | $11.4M | $29.1M | $19.4M | 1.50 | 16,665 |
| Department | Salaries | Direct cost | Paid hours | Average hourly wage | Square feet |
|---|---|---|---|---|---|
| Administrative & general | $15.4M | $78M | 442,931 | $30.91 | 34,030 |
| Employee benefits department | $30,266 | $44.7M | 1,096 | $27.61 | 845 |
| Cap rel costs-mvble equip | $12.7M | ||||
| Cap rel costs-meei main campus | $10.6M | ||||
| Operation of plant-meei main campus | $975,613 | $10.3M | 21,486 | ||
| Central services & supply | $2.8M | $7M | 75,004 | $37.05 | 3,892 |
| Cap rel costs-longwood | $6.2M | ||||
| I&r services-salary & fringes apprv | $5.2M | $6.1M | 2,169 | ||
| Housekeeping | $4.9M | 3,367 | |||
| Operation of plant | $1.4M | $4.7M | 67,145 | $45.23 | 2,082 |
| Cap rel costs-seri (20 staniford st | $4.6M | ||||
| Cap rel costs-bldg & fixt | $4.4M | 428,417 | |||
| Pharmacy | $2.7M | $4.1M | 57,378 | $49.51 | 3,288 |
| Operation of plant-seri | $436,483 | $4M | 152 | ||
| Operation of plant-longwood | $224,104 | $2.7M | 277 | ||
| Nursing administration | $603,867 | $2M | 12,904 | $153.46 | 1,299 |
| Social service | $1.6M | $1.6M | 29,554 | $53.51 | 420 |
| Dietary | $1.5M | $1M | 68,087 | $22.49 | 10,489 |
| Maintenance & repairs | $210,754 | $703,977 | 42,466 | $4.96 | 714 |
| Cap rel costs-meei other off-campus | $621,534 | ||||
| I&r services-other prgm costs apprv | $84,815 | $510,686 | 1,339 | ||
| Laundry & linen service | $483,978 | ||||
| Cap rel costs-other capital | $443,917 | ||||
| Medical records & library | $318,219 | 46 |
Source: CMS cost report (HCRIS, Form 2552-10), report 831166, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Worksheets A, B-1, C Part I and S-3 Part II.
The factors Medicare uses to set what it pays Mass Eye & Ear Infirmary for an inpatient stay.
1.99
Case mix index
Higher than 77% of hospitals paid under Medicare IPPS
Average Medicare DRG weight of its inpatient cases (FY 2027); higher means more complex, costlier care.
Major teaching hospital
Teaching status
0.82 residents per bed
Medicare-funded interns and residents per bed (FY 2027).
22.6%
Low-income patient share
Disproportionate share percentage: Medicaid and SSI patient days CMS uses for safety-net payments (FY 2027).
401
Medicare inpatient stays
Medicare claims CMS based FY 2027 payment rates on.
Urban (metro area)
Location type
Geographic area CMS assigns before any wage index reclassification (FY 2027).
| IPPS fiscal year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | FY 2027 |
|---|---|---|---|---|---|---|---|
| Case mix index | 1.97 | 1.97 | 1.90 | 2.04 | 2.07 | 2.03 | 1.99 |
| Wage index | 1.267 | 1.284 | 1.297 | 1.242 | 1.313 | 1.288 | 1.307 |
| Readmissions adjustment | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Value-based purchasing adjustment | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Medicare inpatient stays | 386 | 386 | 352 | 338 | 347 | 369 | 401 |
Source: CMS IPPS final rule Impact File (FY 2027).
Organizations Mass Eye & Ear Infirmary reports to Medicare as owners or with operational control. 1 individuals also hold ownership interests; they are not listed here.
Mass General Brigham Incorporated
5% or greater direct ownership interest, 100%, since 2018
Sources: CMS Hospital All Owners.
The officers and board members on Mass Eye & Ear Infirmary's Medicare enrollment and on the IRS Form 990 filed under its tax ID.
Source: CMS Hospital All Owners (PECOS), the people the hospital lists on its Medicare enrollment; the first 21 of 24 are shown.
Accountable care organization (Medicare Shared Savings Program)
MASS GENERAL BRIGHAM ACO 2, LLC
ACO A5932, current agreement since 2026. Public reporting page
Source: CMS Shared Savings Program participants, 2026, matched on Mass Eye & Ear Infirmary's legal name.
Helipad
Massachusetts General Hospital
FAA location ID 0MA1, a medical-use heliport at the hospital.
Source: FAA National Airspace System Resource data, cycle 2026-10-01.
About Mass Eye & Ear Infirmary's rates and hospital price transparency.
For MRI brain before and after contrast (CPT 70553), published negotiated rates at Mass Eye & Ear Infirmary range from $934 to $1,289 across 4 insurers. UnitedHealthcare's rate is $934. The median at nearby comparable hospitals is $1,789. What a patient pays depends on their plan's deductible, coinsurance and network status.
For CT abdomen and pelvis with contrast (CPT 74177), published negotiated rates at Mass Eye & Ear Infirmary range from $268 to $1,141 across 4 insurers. Blue Cross Blue Shield's rate is $1,141. The median at nearby comparable hospitals is $2,015. What a patient pays depends on their plan's deductible, coinsurance and network status.
For Colonoscopy with polyp removal (CPT 45385), published negotiated rates at Mass Eye & Ear Infirmary range from $873 to $1,725 across 2 insurers. Blue Cross Blue Shield's rate is $873. What a patient pays depends on their plan's deductible, coinsurance and network status.
For Screening mammography, bilateral (CPT 77067), published negotiated rates at Mass Eye & Ear Infirmary range from $103 to $275 across 2 insurers. Blue Cross Blue Shield's rate is $275. The median at nearby comparable hospitals is $111. What a patient pays depends on their plan's deductible, coinsurance and network status.
Yes. CMS counts 0.82 Medicare-funded residents per bed at Mass Eye & Ear Infirmary for fiscal year 2027, so it is a major teaching hospital.
No. Mass Eye & Ear Infirmary has no Hospital Readmissions Reduction Program penalty in fiscal year 2027.
In 2024, the most common were major head and neck procedures with cc (37 discharges), major male pelvic procedures without cc/mcc (26 discharges), tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc (24 discharges).
Mass Eye & Ear Infirmary's Medicare case mix index is 1.99 for fiscal year 2027, higher than 77% of hospitals paid under the inpatient prospective payment system.
Mass Eye & Ear Infirmary reported 1,553 inpatient discharges and 6,244 inpatient days from Oct 1, 2024 to Sep 30, 2025.
Mass Eye & Ear Infirmary reported 1,569 full-time-equivalent employees on payroll from Oct 1, 2024 to Sep 30, 2025.
Mass Eye & Ear Infirmary reported $347.3M in net patient revenue on $786.1M of gross charges for Oct 1, 2024 to Sep 30, 2025, an operating margin of -31.7%, and net income of $12.3M.
Mass Eye & Ear Infirmary reported $14.1M of unreimbursed and uncompensated care for Oct 1, 2024 to Sep 30, 2025, including $3.9M of charity care at cost.
Insurers' price transparency files list Mass Eye & Ear Infirmary under employer identification number 04-2103591 (Massachusetts Eye & Ear Infirmary). 62 health plans and networks list 04-2103591 for it.
1,012 clinicians who bill Medicare list Mass Eye & Ear Infirmary as a hospital affiliation in CMS's Doctors and Clinicians data. The largest groups are internal medicine physician (196), ophthalmology physician (165), otolaryngology physician (92).
Yes. CMS's Provider of Services file lists The Joint Commission as the accrediting organization for Mass Eye & Ear Infirmary, effective 2011.
In its Medicare enrollment, Mass Eye & Ear Infirmary reports Mass General Brigham Incorporated as 5% or greater direct ownership interest (100%).
CMS lists 22 services at Mass Eye & Ear Infirmary, including Adult Inpatient Psychiatric Care, Anesthesia, Clinical Laboratory, Diagnostic Radiology, Dietary Care, Emergency Department.
In CMS's 2025 Hospital Service Area file, the most Medicare inpatient stays at Mass Eye & Ear Infirmary came from ZIP codes 01930 (11).
Mass Eye & Ear Infirmary has 41 beds, including its psychiatric, rehabilitation and other subprovider units, in its latest Medicare cost report. 42 are Medicare-certified beds in CMS's Provider of Services file. Facility type: Short Term Acute Care Hospital.
Mass Eye & Ear Infirmary is located at 243 Charles Street, Boston, MA 02114. Its main phone number is (617) 523-7900.
Mass Eye & Ear Infirmary's CMS Certification Number (CCN), also called its Medicare provider number, is 220075.
The National Provider Identifier (NPI) on file for Mass Eye & Ear Infirmary is 1639101751.
Mass Eye & Ear Infirmary is affiliated with Mass General Brigham.
Mass Eye & Ear Infirmary lists 33 in-network payers, including Aetna, Ameri Health, Aspirus Health Plan, Avera Health Plans, and is Medicare-certified. Insurance acceptance may vary by plan, so confirm coverage with your insurer or the hospital's billing department.
178 disclosed rate categories. Each shows the payer, category, code type and group with its code range, and contract type, along with how the rate compares with the state average.
Under 45 CFR Part 180, every US hospital must publish a machine-readable file of its standard charges, including gross charges, discounted cash prices and payer-specific negotiated rates, in the CMS template format. PayerPrice can help hospitals publish and maintain these files.
A chargemaster (charge description master, or CDM) is a hospital's master list of billable items, with codes, descriptions and gross charges. A chargemaster review looks at those lines for accuracy and pricing. PayerPrice can help hospitals review their chargemaster; contact us to discuss your needs.
For hospital finance and compliance teams
The data on this page comes from the files hospitals and payers publish. We help hospitals publish theirs correctly, and take a fresh look at their chargemaster.
We turn your chargemaster and payer contracts into the CMS template file, then keep it current as rates change.
{
"description": "MRI of brain (no contrast)",
"code_information": [
{ "code": "611", "type": "RC" },
{ "code": "70551", "type": "CPT" }
],
"standard_charges": [{
"setting": "outpatient",
"minimum": 250,
"maximum": 400,
"gross_charge": 1200,
"discounted_cash": 1080,
"payers_information": [
{
"payer_name": "Platform Health Insurance",
"plan_name": "PPO",
"methodology": "fee schedule",
"standard_charge_dollar": 400
},
{
"payer_name": "Region Health Insurance",
"plan_name": "HMO",
"methodology": "fee schedule",
"standard_charge_dollar": 250
}
]
}]
}Your chargemaster sets the gross charge on every claim, and many payer contracts base payment on it through percent-of-charge, lesser-of and stop-loss terms. We audit it line by line and show how your charges and negotiated rates compare with peer hospitals before your next negotiation.
What a review covers